Nsg 6005 final exam 2024 - Study guides, Class notes & Summaries

NSG 6005 FINAL EXAM 2024/25 Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWER C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state i...

NSG 6005 FINAL EXAM 2024 LATEST VERSION WITH ALL 100 QUESTIONS AND CORRECT VERIFIED ANSWERS ALREADY GRADED A+ (BRAND NEW!!)/ 2024 NSG 6005 FINAL EXAM Cecilia presents with depression associated with complaints of fatigue, sleeping all the time, and lack of motivation. An appropriate initial antidepressant for her would be: A. Fluoxetine (Prozac) B. Paroxetine (Paxil) C. Amitriptyline (Elavil) D. Duloxetine (Cymbalta) - ANSWER-D. Duloxetine (Cymbalta) Sarah, a forty-two-year-old fem...

NSG 6005 FINAL EXAM 2 LATEST 2024 WITH ALL 100 QUESTIONS AND CORRECT VERIFIED ANSWERS ALREADY GRADED A+| NSG 6005 ADVANCED PHARMACOLOGY FINAL EXAM 2 (BRAND NEW!!) Jamie is a thirty-four-year-old pregnant woman with familial hyperlipidemia and elevated LDL levels. What is the appropriate treatment for a pregnant woman? - ANSWER-Bile acid-binding resins An appropriate drug for the treatment of depression with anxiety would be - ANSWER-escitalopram (Lexapro) Dwayne was recently started o...

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL EXAM 2023/2024 100 QUESTIONS WITH ANSWER |GRADED A++ Final Exam Pharmaco

NSG 6005 FINAL Actual Exam 2024 Q & A (Graded A+ )

NSG 6005 FINAL EXAM 2024/2025 UPDATED QUESTIONS WITH 100% CORRECT ANSWERS Disease states in addition to hypertension in which beta blockade is a compelling indication for the use of beta blockers include: A. Heart failure B. Angina C. MI D. Dyslipidemia - ANSWERS C. MI When a patient is on selective-serotonin reuptake inhibitors: A. The complete blood count must be monitored every three to four months B. Therapeutic blood levels must be monitored every six months after a steady state...

NSG 6005 FINAL EXAM 2023/2024 100 QUESTIONS WITH ANSWER |GRADED A++